What was once a niche product has developed into a billion-dollar market that continues to grow rapidly. CBD, which is extracted from the hemp plant, offers a variety of health benefits without the psychoactive effects of THC (tetrahydrocannabinol), the psychoactive component of the cannabis plant.

Numerous scientific studies and field reports show that CBD can be helpful for a variety of ailments and chronic diseases. The global CBD market is experiencing rapid growth. Experts estimate that the market already amounted to over 4.9 billion US dollars in 2022 and is expected to reach over 47 billion US dollars by 2028.

This exponential growth is driven by the increasing awareness of the health benefits of CBD, the legalization of hemp products in many countries and the ongoing research into its therapeutic applications. CBD offers a wide range of health benefits that have been proven by numerous studies. It has anti-inflammatory and pain-relieving effects, making it particularly popular for chronic pain and conditions such as arthritis. It can also reduce anxiety and stress, which many use as a natural alternative to tranquilizers. CBD also supports better sleep and is used for insomnia. In addition, it shows potential neuroprotective effects that could help with neurodegenerative diseases and is increasingly used in skincare to soothe acne and skin irritations.

What is the endocannabinoid system?

The endocannabinoid system (ECS) is a highly complex system that plays a central role in regulating numerous bodily processes, including pain perception, sleep, appetite, immune system, inflammatory responses and emotional stability. It consists of endocannabinoids, endogenous molecules that dock onto special receptors - the CB1 and CB2 receptors - and trigger various reactions in the body. These receptors are located in the brain, the central nervous system and in many organs, which explains the far-reaching effect of the system.

Endocannabinoids are structurally similar to the cannabinoids found in the cannabis plant. This means that substances such as CBD are able to interact with the ECS by modulating the activity of these receptors or slowing down the breakdown of endocannabinoids. CBD does not activate these receptors directly, but indirectly influences their efficiency, which leads to better regulation of the internal balance.

The increasing popularity of CBD products is not a passing trend, but reflects the growing awareness of their health benefits. The CBD market is growing rapidly and more and more people are opting for these natural products to reduce stress, relieve pain and improve their general well-being. With Natura Vitalis CBD products, consumers have the opportunity to choose high-quality products that impress with their innovation and quality.

Natura Vitalis is one of the leading companies in the field of natural food supplements and has also developed an extensive CBD product line to meet the growing needs of consumers. These award-winning products offer natural support for people who want to promote their health in a natural way. Natura Vitalis ensures that all products are of the highest quality, rigorously tested and obtained from sustainable sources. "The cannabis oil extract we use is EU-certified, vegan and free from other additives," says Natura Vitalis founder Frank Felte.